Purchase Order HHSN263201600011A
- Not listed
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
- The Department of Health and Human Services, National Institutes of Health awarded a firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer of goods, for the N4PA SIMOA 2.0 ASSAY KIT. The $112,969.08 award, with an October 2020 completion date, was not set aside. Quanterix has received over $30 million in prior federal contracts from agencies like the NIH, Department of Veterans Affairs, and Department of Defense to supply its ultra-sensitive digital biomarker...
- This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
- This is a firm-fixed-price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Quanterix Corporation, a manufacturer of advanced biomarker detection technology. The $84,525 contract supports Quanterix's work on the Rapid Acceleration of Diagnostics (RADx) initiative for COVID-19 testing. Quanterix is providing specialized Simoa instruments, assay kits, and research services to federal agencies like the NIH,...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Quanterix Corporation for the supply of Neurology 4-Plex A Advantage Kits, SR-X Disc Kits, and Wash Buffers, with a total value of $30,152.63. The award has a completion date of July 31, 2024. Quanterix is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided various products and services...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention's (CDC) Pittsburgh office to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $160,091.47 contract is for the identification of biomarkers for occult diseases, with a completion date of October 27, 2023. Quanterix, the prime contractor, provides advanced instruments, assay kits, and research services to federal government...
- Quanterix Corporation has been awarded a firm fixed price purchase order by the National Institutes of Health National Institute on Aging totaling $12,800.88. The contract has no set-aside designation. Under this award, Quanterix will provide its single molecule array platform and associated assay kits and reagents to support the agency's biomarker detection research efforts. Additionally, Quanterix holds an indefinite delivery contract from the Department of Veterans Affairs Veterans Health...
- This is a firm-fixed-price purchase order awarded by the National Institute of Nursing Research (NINR), a civilian agency, to Quanterix Corporation, a for-profit manufacturer of advanced biomedical equipment and research services. The $24,416.10 contract is for the supply of Quanterix's Simoa HD-X Analyzer, SR-X Biomarker Detection System, and related maintenance services. Quanterix is the prime contractor, and there are no set-aside designations mentioned. The contract award is not associated...
- This federal contract award, valued at $14,525.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Quanterix Corporation, a life sciences company that specializes in ultra-sensitive digital biomarker detection technology. The contract, titled "NICHD - INFLIGHT V2 ADVANTAGE KIT", is a firm-fixed-price purchase order with a completion date of September 30, 2024. Quanterix has also been awarded an indefinite delivery contract (IDV) by the Department...
- This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
This federal contract award, with ID HHSN263201600011A, was issued by the Office of Logistics and Acquisition Operations, a civilian federal agency, to Quanterix Corporation, a for-profit manufacturer of goods. The $112,000.00 firm-fixed-price purchase order is for service-related work, with an ultimate completion date of October 19, 2020. Quanterix Corporation specializes in ultra-sensitive digital biomarker detection technology, providing advanced instruments, assay kits, and research services to various federal agencies like the NIH, VA, and DoD. This contract does not have a set-aside designation. Quanterix also holds an indefinite delivery contract (IDV) valued at up to $2,964,080 from the VA's Veterans Health Administration to provide research services using its single molecule array assays through July 2024. The company has received additional federal grants and contracts to support biomedical research and diagnostic development, particularly for applications in areas such as neurology, infectious diseases, and cancer.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $16.0k | 9/27/19 | |
| P00003 | Exercise an Option | $16.0k | 10/19/18 | |
| 2 | Exercise an Option | $16.0k | 11/7/17 | |
| 1 | Exercise an Option | $16.0k | 11/2/16 | |
| Not listed | Not listed | $16.0k | 10/20/15 |